(NYSE: ACH) Accendra Health's forecast annual revenue growth rate of -23.4% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.03%.
Accendra Health's revenue in 2026 is $6,707,302,000.On average, 7 Wall Street analysts forecast ACH's revenue for 2026 to be $203,421,542,220, with the lowest ACH revenue forecast at $192,128,939,496, and the highest ACH revenue forecast at $219,586,980,366. On average, 6 Wall Street analysts forecast ACH's revenue for 2027 to be $214,714,144,944, with the lowest ACH revenue forecast at $194,526,683,910, and the highest ACH revenue forecast at $230,802,236,496.
In 2028, ACH is forecast to generate $237,608,736,768 in revenue, with the lowest revenue forecast at $230,570,196,714 and the highest revenue forecast at $247,045,021,236.